Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,477 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,477 Cr
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,480.1 Cr -1.3% -6.3% 12% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹100,056.0 Cr -4.3% -6.5% -11.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-1.3%

-6.3%

12%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses